Op-Ed
‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act
February 15, 2024
No Comments
The Biden administration should not support a WTO petition to strip IP protections from Covid-19 treatments
January 31, 2024
No Comments
White House’s Drug Patent Plan Undercuts Research and Innovation
January 9, 2024
No Comments
Noncompete legislation will hamper New York’s high tech industry
December 3, 2023
No Comments